Current Events in January 2000

Browse Current Events by year

2000

Browse Current Events by month

Get trending consumer news and recalls

    By entering your email, you agree to sign up for consumer news, tips and giveaways from ConsumerAffairs. Unsubscribe at any time.

    Thanks for subscribing.

    You have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.

    Judge Orders Alpine To Stop Making Unsupported Claims

    Ozone "Air Cleaners" Slapped

    A federal judge has ordered Alpine Industries, Inc., a Greenville, Tennessee, manufacturer of ozone generating air treatment machines to stop claiming that their machines provide relief from any medical condition or remove a wide variety of indoor air pollutants.

    The interim injunction follows a November 1, 1999, verdict where a Federal jury found unanimously that Alpine Industries violated a 1995 Federal Trade Commission order by failing to have "competent and reliable scientific evidence" to support hundreds of claims for their products. Alpine was also found to make unsupported claims that its products control indoor ozone levels.

    The injunction orders Alpine to notify their thousands of dealers that they cannot make any of these claims.

    "What's particularly unconscionable is that the company used unsupported health-benefit claims to tout an expensive product to consumers in clear violation of an FTC order," said Jodie Bernstein, Director of the FTC's Bureau of Consumer Protection.

    "This case violates the basic laws of advertising. If a business makes a claim about a product or service, it had better have evidence to support the claim."

    The jury returned a verdict after a 13-day trial and six days of deliberations. It determined that Alpine claimed that Alpine products would prevent or provide relief from various health or medical conditions, including allergies, asthma, sinus and breathing problems, emphysema, lupus, migraine headaches and an unspecified incurable eye disease. The jury determined that these claims lacked competent and reliable scientific support.

    The jury decided that the defendants made claims in their marketing materials that Alpine products removed or reduced various pollutants from indoor air, including mold, mildew, dust, viruses, insect parts, insect eggs, dead human skin, human hair, chemical gases, formaldehyde and other contaminants.

    The jury also decided that Alpine claimed that Alpine products reduced or removed from the air a variety of bacteria and viruses, including streptococcus, staphylococcus, e. coli bacteria, Aspergillus fungus, candida yeast, salmonella, legionella, and tuberculosis bacillus. The jury found that these air cleaning claims (with the exception of claims relating to cigarette smoke, tobacco smoke and smoke removal) were not supported by competent and reliable scientific evidence.

    The jury further decided that the defendants' claims that Alpine machines could control the ambient level of indoor ozone using a sensor installed in the machine were not supported by competent and reliable scientific evidence.

    The interim injunction is the first step in the ongoing "remedies" phase of the case. The court will decide later the amount of the penalty, whether to order restitution to consumers and the specific terms of a permanent injunction.

    Alpine Industries is a privately held, multi-level marketing plan that claims to have between 75,000 and 100,000 active dealers nationwide. Its main facilities are in Greene County, Tennessee. William J. Converse is the company's president and chief executive officer. Michael Jackson is vice-president and heads the company's marketing activities. The flagship product of Alpine Industries is the XL-15, which sells for approximately $600 per unit.

    The United States was represented in this litigation by Elizabeth Stein, of the Department of Justice's Office of Consumer Litigation, Helen Smith, of the U. S. Attorneys Office and Elena Paoli, of the Federal Trade Commission.

    Judge Orders Alpine to stop making unsupported claims about its air cleaners...

    Credit Agencies

    The nation's three largest consumer credit reporting agencies have agreed to pay $2.5 million to settle charges that they failed to consistently answer consumer calls on their toll-free lines during office hours.

    Equifax, Trans union and Experian agreed to pay monetary settlements and to staff up their call centers so that their blocked call rate is no more than 10 percent and the average holding time is no greater than three minutes, 30 seconds.

    The Federal Trade Commission brought the action against the companies under the Fair Credit Reporting Act (FCRA).

    The FCRA is intended to ensure that consumers are able to resolve inaccuracies in their credit reports. It requires that the credit bureaus operate toll-free numbers accessible to consumers during normal business hours.

    "The reality is that consumers never got the access that the law guarantees," said Jodie Bernstein, Director of the FTC's Bureau of Consumer Protection. "These cases demonstrate in no uncertain terms that it's time for Equifax, Experian and Trans Union to pick up the phone and meet their obligations to consumers."

    The FTC's complaints against Trans Union and Experian charge that since September 1997, more than one million calls to their toll-free numbers were met with a busy signal or a recorded message. The complaint against Equifax is similar, saying hundreds of thousands of calls went unanswered.

    The complaint also charges that consumers endured "unreasonable" periods of hold, trying to speak to someone about their credit records.

    The companies are also accused of purposely blocking calls from certain locations and area codes.

    Credit Agencies Experian, Trans Union, Equifax Charged with Violations...

    FDA Targets Blue Nitro, GBL Drugs

    FDA Targets Popular Supplement

    WASHINGTON, Jan. 7, 2000 -- A dietary supplement popular with athletes and fitness fiends is implicated in at least six deaths and the Food and Drug Administration (FDA) is trying to shut down suppliers of the substance.

    The substance, gamma butyrolactone, or GBL, is marketed under a number of brand names, including Blue Nitro, Firewater, Invigorate, Vitality, Insom-X and GH Revitalizer. .

    Athletes take it to aid in sleep after an intense workout. It's also thought to have muscles recover more quickly.

    The supplement is being blamed for the recent near-fatal seizure suffered by Phoenix Suns forward Tom Gugliotta. He suffered a seizure on the team bus after a game in Portland Dec. 17 and was hospitalized in serious condition.

    The Suns' team doctor said Gugliotta told him he had taken a supplement containing GBL because he had been having trouble sleeping.

    GBL is widely sold, both as a liquid and powder, at gyms and fitness centers, through the Internet and in some health-food stores.

    The FDA says the drug can cause dangerously low respiratory rates, leading to unconsciousness, coma and death. As an industrial product, the substance is used as a paint stripper.

    The FDA's Office of Criminal Investigations said that as of Dec. 16, 1999, the day before Gugliotta's seizure, it had recorded 116 arrests, 55 convictions and 38 indictments. The agency is actively scanning the Internet and searching retail shelves for the product.

    The drug's not only dangerous, there's also no proof it works, FDA scientists said. They said those selling the drug are "opportunists."

    Promoters of the drug also claim it can help with weight loss and stress reduction.

    GBL products may be labeled as containing 2(3H)-furanone dihydro, butyrolactone, gamma-butyrolactone, 4-butyrolactone, dihyro-2(3H)-furanon, 4-butanolide and tetrahydro-2-furanone.

    FDA Targets GBL drugs, blue nitro, firewater, invigorate, after deaths and seizures...

    Get trending consumer news and recalls

      By entering your email, you agree to sign up for consumer news, tips and giveaways from ConsumerAffairs. Unsubscribe at any time.

      Thanks for subscribing.

      You have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.